Document Detail


Food and Drug Administration guidance: supervisory responsibilities of investigators.
MedLine Citation:
PMID:  21527116     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Conducting clinical trials for diabetes can present researchers with a number of regulatory questions. The Food and Drug Administration (FDA) has increased regulatory enforcement at clinical sites, with an increased emphasis on oversight by principal investigators (PIs; referred to by the FDA as the clinical investigator). The FDA has issued a guidance document, "Guidance for Industry: Investigator Responsibilities-Protecting the Rights, Safety, and Welfare of Study Subjects" (2009), to assist investigators and sponsors. This guidance document breaks new ground regarding the FDA's expectations for investigator oversight of subinvestigators and study staff. The guidance document corresponds with a sharp increase in FDA warning letters to PIs for noncompliance with good clinical practice regulatory requirements. For the first time, an FDA guidance document discusses issues such as the delegation of authority, standard operating procedures, and training of study staff. The FDA provides specific examples with particular emphasis given to appropriate delegation of duties by the PI and ensuring that the clinical staff entrusted to carry out the trial has had adequate training and experience in order to allow them to perform the designated tasks.
Authors:
Carl Anderson; Patti A Young; Ann Berenbaum
Related Documents :
18517216 - Influence of a rare sugar, d-psicose, on the physicochemical and functional properties ...
8475146 - A positive response to an adverse reaction. diagnosis and management of food intoleranc...
17045166 - Biodistribution and catabolism of 18f-labeled n-epsilon-fructoselysine as a model of am...
106746 - Oral cromoglycate: its value in the treatment of adverse reactions to foods.
20630886 - Prosocial behaviour emerges independent of reciprocity in cottontop tamarins.
10349956 - Bacitracin versus mupirocin for staphylococcus aureus nasal colonization.
Publication Detail:
Type:  Journal Article; Review     Date:  2011-03-01
Journal Detail:
Title:  Journal of diabetes science and technology     Volume:  5     ISSN:  1932-2968     ISO Abbreviation:  J Diabetes Sci Technol     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-04-29     Completed Date:  2011-11-29     Revised Date:  2012-03-01    
Medline Journal Info:
Nlm Unique ID:  101306166     Medline TA:  J Diabetes Sci Technol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  433-8     Citation Subset:  IM    
Copyright Information:
© 2011 Diabetes Technology Society.
Affiliation:
Carl A. Anderson, LLC, Tacoma, Washington 98407, USA. carl11anderson@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Child
Clinical Trials as Topic*
Equipment and Supplies
Ethics, Research*
Humans
Research Design
United States
United States Food and Drug Administration

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chr...
Next Document:  Prevalence and clinical profile of metabolic obesity and phenotypic obesity in Asian Indians.